EAU 2014

eau29th Annual European Association
of Urology (EAU) Congress
April 11 - 15, 2014

Stockholm, Sweden

#AUA14 - Early experience of radium-223 treatment for metastatic castrate resistant prostate cancer: A preliminary report - Session Highlights

ORLANDO, FL USA (UroToday.com) - Radium-223 has recently been introduced for the treatment of metastatic castrate resistant prostate cancer (mCRPC).

#AUA14 - Analysis of renal mass biopsy prior to extirpative surgery and validation of the Michigan Risk Stratification algorithm - Session Highlights

ORLANDO, FL USA (UroToday.com) - Dr. Hak Lee reviewed data of 47 patients undergoing renal mass biopsy (RMB) prior to curative intent surgery for small cortical renal masses. 96% of patients had CT-guided biopsy, and the average mass was 3.5 cm in diameter.

#AUA14 - Pilot evaluation of boiling histotripsy of the kidney: Assessment in human ex vivo kidneys and validation of the porcine model - Session Highlights

ORLANDO, FL USA (UroToday.com) - Histotripsy is a non-thermal pulsed high-intensity focused ultrasound technology that homogenizes a target tissue.

#AUA14 - Does fellow and chief-resident training affect perioperative outcomes of robot-assisted radical prostatectomy? - Session Highlights

ORLANDO, FL USA (UroToday.com) - Medical education has long had to strike a balance when providing adequate training to novices and young doctors.

#AUA14 - Crossfire: Controversies in Urology - Robots have made a difference in the outcomes for prostate cancer patients - Session Highlights

ORLANDO, FL USA (UroToday.com) - This reboot of the debate on robotic versus open radical prostatectomy (RP), proclaimed the “pterodactyls” (open debaters) versus the “hucksters” (robotics debaters) by moderator Dr. Joseph Smith, featured a face-off between Drs. Ashutosh Tewari and Mani Menon on the pro-side, for the robot, versus Drs. Joel Nelson and Herbert Lepor on the con-side.

EAU 2014 - Poster: A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC)

STOCKHOLM, SWEDEN (UroToday.com) - Presented by D Petrylak,1 D Smith,2 L Appleman,3 M Fleming,4 A Hussain,5 R Dreicer,6 AO Sartor,7 N Shore,8 NJ Vogelzang,9 H Youssoufian,10 VA DiPippo,10 N Stambler,10 K Huang,10 RJ Israel10 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

EAU 2014 - Poster: Safety and efficacy of ODM-201 in chemotherapy and CYP17-inhibitor naïve patients: Analysis of data from the ARADES and the ARAFOR trials

STOCKHOLM, SWEDEN (UroToday.com) - Presented by T. Tammela,1 C. Massard,2 P. Bono,3 P. Langmuir,4 J. Aspegren,5 A. Vuorela,5 M.V.J. Mustonen,5 and K. Fizazi2 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe